We showed the epigenetic inactivation of RASSF10 in breast cancer [26], lung cancer [20], skin cancer [27], and thyroid cancer [21] and showed that RASSF10 inhibited the growth of breast cancer [26], pancreas carcinoma, and sarcoma cell lines [20]. Here, RASSF10 is linked to skin neoplasm.